H5N1 Influenza: Clinical Trials

4 trials for H5N1 Influenza, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting. 2 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1
Phase 31Completed 1
Phase 41Active not recruiting 1

Follow H5N1 Influenza: new trials by email Literature Review of H5N1 Influenza trials Research Report on H5N1 Influenza

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart
H5N1 vaccine (Arepanrix), Saline (as a placebo) - H5N1 Influenza, H5N1 Virus
Phase 4Active not recruitingCanadian Immunization Research Network3122025-10-142026-01-16
Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
H5N1 Vaccine - H5N1 Influenza
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)692011-10-012016-02-09
Experimental AD4-H5-VTN Vaccine in Healthy Volunteers
Ad4-H5-VTN vaccination-tonsillar route, Ad4-H5-vaccination-oral route - H5N1 Influenza
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)962011-09-142019-12-16
H5N1 Vaccine Study in Japanese Adults
H5N1 (pre-)pandemic influenza vaccine (whole virion, Vero Cell derived, inactivated) - H5N1 Influenza
Phase 2 / Phase 3CompletedAlachua Government Services, Inc.3402011-06-012015-10-09

Narrower conditions

Influenza in Birds (2)  ·  Adenoviridae Infections (1)  ·  Influenza, Human (1)

Broader conditions

Infections (3)  ·  Orthomyxoviridae Infections (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  Animal Diseases (2)  ·  Bird Diseases (2)  ·  DNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)

Interventions

Saline Solution (1)  ·  Sodium Chloride (1)  ·  arepanrix (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Alachua Government Services, Inc. (1)  ·  Canadian Immunization Research Network (1)

Countries

United States (2)  ·  Canada (1)  ·  Japan (1)

Top investigators

Alexander Geisberger, MD (1)  ·  Joanne M Langley (1)  ·  Kawsar R. Talaat, MD (1)  ·  Mark Connors, M.D. (1)

Results publications

PMID 24604819, PMID 33529172